A multiregion analysis of the ESCC tumors of 28 patients showed that copy number gains of the MYC locus, responsible for c-myc amplification, are associated with poor PFS and OS; c-myc amplification remained during the course and was potentially identified as a main genetic mechanism of resistance to chemoradiotherapy [39]. Here, MYC is linked to esophageal squamous cell carcinoma.